Michelle McMurry-Heath - 07 Nov 2025 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: Director
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 07 Nov 2025
Net transactions value: -$131,255
Form type: 4
Filing time: 10 Nov 2025, 17:08:51 UTC
Previous filing: 04 Jun 2025
Next filing: 25 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
McMurry-Heath Michelle	Director	4721 EMPEROR BOULEVARD, SUITE 100, DURHAM	/s/ Anthony D'Adamio, Attorney-in-Fact	10 Nov 2025	0001904156

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Sale	$131,255	-17,701	-24%	$7.42	56,997	07 Nov 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.36 to $7.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.36 to $7.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.